溶解性 | DMSO 30 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
存贮条件 | 储存温度-20°C |
应用 | The free base form of an FGFR inhibitor |
产品介绍 | Dovitinib (TKI-258, CHIR-258)是一种多靶点的RTK抑制剂,对III型(FLT3/c-Kit)作用最强,IC50为1 nM/2 nM,同时也作用于IV类(FGFR1/3)和V类(VEGFR1-4) RTKs,IC50为8-13 nM,但对InsR, EGFR, c-Met, EphA2, Tie2, IGF-1R和HER2作用较弱。 |
备注 | Dovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-M |
生化机理 | Dovitinib, Free Base, is the non-salt form of dovitinib, lactate salt (sc-396753). Dovitinib is a multitargeted growth factor receptor kinase inhibitor to VEGFR, FGFR3, PDGFR and c-KIT. |
别名 | CHIR-258;多韦替尼; 4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮;CHIR-258;TKI258;TKI-258;TKI 258;CHIR258;CHIR 258;4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one |
多维替尼 (TKI-258, CHIR-258)
Dovitinib (TKI-258, CHIR-258) (订货以英文为准)
编号:D126778
CAS号:405169-16-6
分子式:C21H21FN6O
分子量:392.43
产品名称 | Dovitinib (TKI-258, CHIR-258) |
中文名称 | 多维替尼 (TKI-258, CHIR-258) |
CAS号 | 405169-16-6 |
分子式(M.F.) | C21H21FN6O |
分子量(M.W.) | 392.43 |
储存条件 | -20°C储存 |
标识符号 | https://www.aladdin-e.com/images/ghs/ghs07.jpg |
信号词 | Warning |
危害声明 | H315-H319-H335 |
警示性声明 | P261-P305 + P351 + P338 |
个人防护设备 | dust mask type N95 (US), Eyeshields, Gloves |
WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品